Table 2 1-, 3-, and 5-year survival rate of H-CHOP and R-CHOP for the overall population, those who had completed 6 cycles of treatment, IPI 1, and IPI 2
Survival rate (95% CI) | OS | PFS | |||||
|---|---|---|---|---|---|---|---|
H-CHOP | R-CHOP | H-CHOP | R-CHOP | ||||
Overall population | 1-year | 93.6 (89.9–97.5) | 94.3 (90.8–98.0) | 92.3 (88.3–96.6) | 91.8 (87.7–96.2) | ||
3-year | 87.8 (82.8–93.1) | 85.5 (80.2–91.2) | 83.2 (77.6–89.3) | 82.4 (76.7–88.5) | |||
5-year | 81.0 (74.9–87.5) | 75.4 (68.9–82.6) | 77.7 (71.4–84.6) | 73.0 (66.3–80.3) | |||
Patients who had completed 6 cycles of treatment | 1-year | 95.6 (92.3–99.1) | 95.9 (92.7–99.2) | 94.1 (90.3–98.2) | 93.8 (90.0-97.8) | ||
3-year | 90.4 (85.6–95.5) | 86.3 (80.9–92.1) | 85.2 (79.4–91.4) | 83.6 (77.8–89.8) | |||
5-year | 83.3 (77.2–90.0) | 77.6 (71.0-84.8) | 79.6 (73.0-86.8) | 75.6 (68.9–83.0) | |||
IPI 1 | 1-year | 95.7 (91.1–100) | 95.2 (90.7–99.9) | 94.3 (89.0-99.9) | 95.2 (90.7–99.9) | ||
3-year | 89.9 (83.1–97.3) | 89.2 (82.7–96.1) | 84.1 (76.0-93.2) | 85.5 (78.3–93.5) | |||
5-year | 86.8 (79.0-95.2) | 80.2 (71.9–89.4) | 84.1 (76.0-93.2) | 75.3 (66.4–85.3) | |||
IPI 2 | 1-year | 91.5 (95.6–97.7) | 92.9 (87.0-99.1) | 90.2 (84.0-96.9) | 87.1 (79.6–95.3) | ||
3-year | 86.5 (79.4–94.3) | 80.0 (71.2–89.9) | 82.7 (74.8–91.4) | 87.1 (67.9–87.6) | |||
5-year | 76.2 (67.4–86.2) | 68.0 (57.7–80.0) | 72.0 (62.6–82.7) | 68.2 (58.0-80.1) | |||